688278.SS
Price:
$72.48
Market Cap:
$29.48B
Xiamen Amoytop Biotech Co., Ltd. engages in the manufacture, marketing, and sale of recombinant protein drugs using genetic engineering technology in China. It offers formulations, reagents, and APIs, as well as custom-manufacturing services. The company was founded in 1996 and is based in Xiamen, China.
Industry
Biotechnology
IPO Date
2020-01-17
Stock Exchange
SHH
Ticker
688278.SS
According to Xiamen Amoytop Biotech Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 5.56. This represents a change of 21.49% compared to the average of 4.57 of the last 4 quarters.
The mean historical Current Ratio of Xiamen Amoytop Biotech Co., Ltd. over the last ten years is 3.70. The current 5.56 Current Ratio has changed 14.93% with respect to the historical average. Over the past ten years (40 quarters), 688278.SS's Current Ratio was at its highest in in the March 2021 quarter at 7.99. The Current Ratio was at its lowest in in the September 2018 quarter at 0.
Average
3.70
Median
3.32
Minimum
2.28
Maximum
6.72
Discovering the peaks and valleys of Xiamen Amoytop Biotech Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 127.63%
Maximum Annual Current Ratio = 6.72
Minimum Annual Increase = -29.97%
Minimum Annual Current Ratio = 2.28
Year | Current Ratio | Change |
---|---|---|
2024 | 4.34 | 30.83% |
2023 | 3.32 | -6.93% |
2022 | 3.57 | -24.24% |
2021 | 4.71 | -29.97% |
2020 | 6.72 | 127.63% |
2019 | 2.95 | 2.74% |
2018 | 2.87 | 15.41% |
2017 | 2.49 | 9.08% |
The current Current Ratio of Xiamen Amoytop Biotech Co., Ltd. (688278.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.74
5-year avg
4.53
10-year avg
3.70
Xiamen Amoytop Biotech Co., Ltd.’s Current Ratio is greater than Sinocelltech Group Limited (0.73), greater than Suzhou Zelgen Biopharmaceuticals Co., Ltd. (1.88), greater than Zhejiang Orient Gene Biotech Co., Ltd. (4.04), less than null (0), less than null (0),
Company | Current Ratio | Market cap |
---|---|---|
0.73 | $21.79B | |
1.88 | $31.02B | |
4.04 | $4.95B | |
0 | $0 | |
0 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xiamen Amoytop Biotech Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Xiamen Amoytop Biotech Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Xiamen Amoytop Biotech Co., Ltd.'s Current Ratio?
How is the Current Ratio calculated for Xiamen Amoytop Biotech Co., Ltd. (688278.SS)?
What is the highest Current Ratio for Xiamen Amoytop Biotech Co., Ltd. (688278.SS)?
What is the 3-year average Current Ratio for Xiamen Amoytop Biotech Co., Ltd. (688278.SS)?
What is the 5-year average Current Ratio for Xiamen Amoytop Biotech Co., Ltd. (688278.SS)?
How does the current Current Ratio for Xiamen Amoytop Biotech Co., Ltd. (688278.SS) compare to its historical average?